Aureka Biotechnologies
Builds biological foundation models and closed-loop infrastructure for drug discovery
$100MSeries B
Role not disclosedM
MPCi
Activity from announced rounds
Activity in this selectionnrw-venture-f5757e51
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $127.7M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionExcalipoint Therapeutics
Develops next-generation T-cell engager therapies for cancer and autoimmune diseases
$27.7MSeed+
Role not disclosed